🎉 Founding Member Beta — Join our Discord and get 3 months of Pro free. Learn more →

Braveheart Bio, Inc.

BRVE Healthcare
$20.39 +$1.12 (5.81%)
Market Cap: $1.67 B
Gurus Holding
1
Popularity Rank
#4423
% of Shares Held
0.10%
Net Activity (Q3 2026)
+$1.59 M

Guru Ownership Trend

Guru Analysis for Braveheart Bio, Inc. (BRVE)

Braveheart Bio, Inc. (BRVE), a key player in the Healthcare sector, continues to attract institutional attention.

As of Q3 2026, a total of 1 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $1.6 M.

Top institutional holders include Louis Moore Bacon.

Institutional sentiment is currently Bullish. This is evidenced by a $1.59 M net inflow during the quarter.

Recent activity highlights Louis Moore Bacon who opened a new position.

Key Holders

Top 5 by Value

Top 5 by Conviction

Recent Activity Breakdown (Q3 2026)

+$1.59 M
Total Buy Value
New Buys 1
Additions 0
-$0
Total Sell Value
Reductions 0
Sold Out 0

Guru Consensus (Q3 2026)

Based on recent activity
Net Sellers
0
Net Buyers
1

FAQs for Braveheart Bio, Inc. (BRVE)

Major holders include Louis Moore Bacon ($1.59 M). According to the latest reported data, 1 tracked investment managers collectively hold approximately 78,715 shares.

According to the latest 13F reporting period, sentiment appears Bullish (Net Buying). There was a net inflow of $1.59 M, with 1 managers increasing positions and 0 managers reducing holdings.

No tracked managers reduced or fully exited their positions in BRVE during the most recent reporting period.

Yes, 1 managers opened new positions in BRVE, and 0 increased their existing holdings. The total reported buy value was $1.59 M.

Portfolio Manager % Portfolio Activity Shares Value Report Date
0.03% New Buy 78,715 $1.59 M Q3 2026
Date
Insider Name
Transaction
Value
Shares
Position / Chg
SEC Form